Effects of recombinant murine (rm) interleukin-12 and rm interferon-gamma in mice infected with Bordetella pertussis

J Infect Dis. 1996 Oct;174(4):786-9. doi: 10.1093/infdis/174.4.786.

Abstract

The recombinant cytokines interferon (IFN)-gamma and interleukin (IL)-12 stimulate several macrophage-mediated functions that are important in host defense. An experimental pertussis model showed that intraperitoneal (i.p.) administration of 10,000 U of recombinant murine (rm) IFN-gamma to mice at the time of Bordetella pertussis infection caused a marked and significant reduction in the number of colony-forming units of bacteria in the lungs. Administration i.p. of 1 microgram of rmIL-12 or 1 microgram of rmIL-12 at the time of and for 5 consecutive days after B. pertussis challenge also induced a significant reduction in the number. However, i.p. administration of 1 microgram of rmIL-12 with 10,000 U of IFN-gamma at the time of B. pertussis challenge did not provide protection. These findings indicate that exogenous administration of rmIL-12 and rmIFN-gamma enhances resistance of mice to B. pertussis infection.

MeSH terms

  • Animals
  • Female
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / therapeutic use*
  • Interleukin-12 / therapeutic use*
  • Mice
  • Recombinant Proteins / therapeutic use
  • Whooping Cough / therapy*

Substances

  • Recombinant Proteins
  • Interleukin-12
  • Interferon-gamma